FI941920A0 - Menetelmä ja koostumus bioaktiivisten substanssien immunologisen aktiivisuuden määrittämiseksi - Google Patents

Menetelmä ja koostumus bioaktiivisten substanssien immunologisen aktiivisuuden määrittämiseksi

Info

Publication number
FI941920A0
FI941920A0 FI941920A FI941920A FI941920A0 FI 941920 A0 FI941920 A0 FI 941920A0 FI 941920 A FI941920 A FI 941920A FI 941920 A FI941920 A FI 941920A FI 941920 A0 FI941920 A0 FI 941920A0
Authority
FI
Finland
Prior art keywords
bioactive substances
immunological activity
tested
solution
composition
Prior art date
Application number
FI941920A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI941920L (fi
FI941920A7 (fi
Inventor
Anna Inglot
Zofia Blach-Olszewska
Original Assignee
Torf Ets
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Torf Ets filed Critical Torf Ets
Publication of FI941920L publication Critical patent/FI941920L/fi
Publication of FI941920A7 publication Critical patent/FI941920A7/fi
Publication of FI941920A0 publication Critical patent/FI941920A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A61K35/10—Peat; Amber; Turf; Humus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FI941920A 1991-10-26 1992-09-28 Menetelmä ja koostumus bioaktiivisten substanssien immunologisen aktiivisuuden määrittämiseksi FI941920A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP91118269A EP0539610A1 (en) 1991-10-26 1991-10-26 Method and composition for determining the immunological activity of solutions containing active substances
PCT/EP1992/002228 WO1993008470A1 (en) 1991-10-26 1992-09-28 Method and composition for determining the immunological activity of bioactive substances

Publications (3)

Publication Number Publication Date
FI941920L FI941920L (fi) 1994-04-25
FI941920A7 FI941920A7 (fi) 1994-04-25
FI941920A0 true FI941920A0 (fi) 1994-04-25

Family

ID=8207282

Family Applications (1)

Application Number Title Priority Date Filing Date
FI941920A FI941920A0 (fi) 1991-10-26 1992-09-28 Menetelmä ja koostumus bioaktiivisten substanssien immunologisen aktiivisuuden määrittämiseksi

Country Status (22)

Country Link
US (1) US5543300A (OSRAM)
EP (2) EP0539610A1 (OSRAM)
JP (1) JPH07500905A (OSRAM)
AT (1) ATE153763T1 (OSRAM)
AU (1) AU678343B2 (OSRAM)
BG (1) BG61705B1 (OSRAM)
CA (1) CA2122131A1 (OSRAM)
CZ (1) CZ100494A3 (OSRAM)
DE (3) DE539610T1 (OSRAM)
DK (1) DK0609255T3 (OSRAM)
ES (1) ES2061424T3 (OSRAM)
FI (1) FI941920A0 (OSRAM)
GR (3) GR930300100T1 (OSRAM)
HU (1) HU216863B (OSRAM)
LV (1) LV12140B (OSRAM)
NO (1) NO941444L (OSRAM)
PL (1) PL170592B1 (OSRAM)
RO (1) RO114837B1 (OSRAM)
RU (1) RU2125727C1 (OSRAM)
SG (1) SG72665A1 (OSRAM)
SK (1) SK44094A3 (OSRAM)
WO (1) WO1993008470A1 (OSRAM)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19615470A1 (de) * 1996-04-19 1997-10-23 Heinz Beinio Körperpflegemittel und Verfahren zu seiner Herstellung
ATE316379T1 (de) * 1998-09-23 2006-02-15 Pfeinsmith Ltd Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen
RU2180120C1 (ru) * 2000-07-05 2002-02-27 Научно-исследовательский институт детских инфекций Способ выявления цитокинов
GB0101973D0 (en) * 2001-01-25 2001-03-14 Statens Seruminstitut Improved in vitro diagnostic method of detecting a cell-mediated immune response
RU2226275C2 (ru) * 2002-04-15 2004-03-27 Научно-исследовательский и учебно-методический центр биомедицинских технологий ВИЛАР Способ определения цитотоксического эффекта и ростстимулирующей активности веществ для доклинических испытаний
EP1449535B1 (en) * 2003-02-18 2006-05-03 Clinique La Prairie Research SA Compositions comprising fetal hemoglobin and bacterial endotoxin and optionally additional fetal liver components
US7497947B2 (en) * 2004-04-14 2009-03-03 Embro Corporation Devices for water treatment
US7614340B2 (en) * 2007-02-09 2009-11-10 Honeywell International Inc. Composite piston housing for aircraft brakes
CA2845931C (en) 2011-09-07 2016-07-12 Embro Corporation Use of moss to reduce disinfection by-products in water treated with disinfectants
US9795809B2 (en) 2013-12-23 2017-10-24 Embro Corporation Use of moss to improve dental health
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH636448A5 (en) * 1977-05-06 1983-05-31 Horst Veith Process for the determination of the effect of substances on constituents of the blood for the detection of infectious and immunological processes and composition for carrying it out
NZ214400A (en) * 1985-12-02 1989-05-29 Univ Otago Detecting infection in ruminant including conducting assay of mononuclear cell function
EP0238851B1 (en) * 1986-02-19 1992-12-09 Imreg, Inc. A method and means of assaying an immune system
ATE77488T1 (de) * 1986-03-06 1992-07-15 Commw Scient Ind Res Org In-vitro-testverfahren zum nachweis zellulaerer immunresponsen.
US5096708A (en) * 1988-07-07 1992-03-17 Sven Gohla Medical preparation containing as active agent a component from thuja plants which comprises polysaccharides
WO1992016600A1 (en) * 1991-03-16 1992-10-01 Torf Establishment Process for the extraction of peat and apparatus for carrying out the process

Also Published As

Publication number Publication date
GR940300077T1 (en) 1994-11-30
FI941920L (fi) 1994-04-25
PL170592B1 (en) 1997-01-31
CA2122131A1 (en) 1993-04-29
SG72665A1 (en) 2000-05-23
DE69220078T2 (de) 1997-12-04
ATE153763T1 (de) 1997-06-15
RU2125727C1 (ru) 1999-01-27
HUT69990A (en) 1995-09-28
EP0539610A1 (en) 1993-05-05
DE539610T1 (de) 1993-12-16
EP0609255B1 (en) 1997-05-28
GR3024457T3 (en) 1997-11-28
ES2061424T3 (es) 1997-10-01
AU2650992A (en) 1993-05-21
HU9401185D0 (en) 1994-07-28
WO1993008470A1 (en) 1993-04-29
BG61705B1 (bg) 1998-03-31
LV12140B (lv) 1998-12-20
FI941920A7 (fi) 1994-04-25
HK1002610A1 (en) 1998-09-04
JPH07500905A (ja) 1995-01-26
NO941444L (no) 1994-06-16
DE609255T1 (de) 1995-06-14
NO941444D0 (no) 1994-04-21
AU678343B2 (en) 1997-05-29
GR930300100T1 (OSRAM) 1993-10-29
LV12140A (lv) 1998-09-20
CZ100494A3 (en) 1994-11-16
HU216863B (hu) 1999-09-28
DK0609255T3 (da) 1997-12-22
BG98720A (bg) 1995-07-28
RO114837B1 (ro) 1999-07-30
US5543300A (en) 1996-08-06
RU94022481A (ru) 1996-09-27
ES2061424T1 (es) 1994-12-16
EP0609255A1 (en) 1994-08-10
SK44094A3 (en) 1995-03-08
DE69220078D1 (de) 1997-07-03

Similar Documents

Publication Publication Date Title
Lampson et al. Purification and characterization of chick embryo interferon
DE58908972D1 (de) Aldimino- oder ketimino-oxy-ortho-tolylacrylsäure-methylester, ihre herstellung und diese enthaltende fungizide.
ATE247282T1 (de) Verfahren zur identifizierung von hemmstoffe der produktion des beta-amyloidpeptids
FI941920A0 (fi) Menetelmä ja koostumus bioaktiivisten substanssien immunologisen aktiivisuuden määrittämiseksi
FI881061A0 (fi) Kompositioner med foerdroejd frigoerelse foer parenteralt bruk och deras anvaendning.
DE68906735D1 (de) Pharmazeutische zubereitung zur behandlung von viruskrankheiten mit leber-extrakt.
DK1092437T3 (da) Anvendelse af epidermal vækstfaktor som et gastrointestinalt terapeutisk middel
BG47034A3 (bg) Метод за получаване на 7-//мета-заместени/-пеницилини/- -1-карба-1-детиацефалоспорини
DE3884680D1 (de) Äusseres Membranprotein F von Pseudomonas aeruginosa.
NO893135L (no) Fremgangsmaate for fremstilling av n-2,3-butadienyl tri- og tetraaminoalkanderivater.
BE1003255A5 (fr) Acides (rs)-2-(2,3-dihydro-5-hydroxy-4,6,7-trimethylbenzofurannyl)-acetiques et acides 2-(2,3-dihydro-5-acyloxy-4,6,7-trimethylbenzo-furannyl)-acetiques et leurs esters mucoregulateurs et anti-ischemiques et procede pour les preparer.
ATE59780T1 (de) Pharmazeutische zusammensetzung zur behandlung von tumoren.
DE3585416D1 (de) Verfahren zur herstellung eines biologischen stoffes.
DK113789A (da) Thiosulfinsyrederivater, deres anvendelse til behandling af betaendelsessygdomme samt laegemiddel indeholdende disse stoffer
ATE4216T1 (de) 3-hydrocarbylthio-2-acyloxypropyl 2trimethylammonioethyl phosphate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen.
DK183788A (da) Fremgangsmaade til foroegelse af levedygtigheden af frysetoerrede, maelkesyreproducerende bakteriekulturkoncentrater
DE3650368D1 (de) Verwendung von Depogen zur Behandlung von eingeschränktem Blutkreislauf.
ATE135702T1 (de) Aryl- oder heteroaryl-1-alkyl-pyrrol-2- carbonsäure-derivate, zur behandlung von durch interleukin-1 hervorgerufenen erkrankungen
FR2580648B1 (fr) Nouveaux derives du triazole, leur procede de preparation et les compositions pharmaceutiques les renfermant
DE3876425D1 (de) Gesteuerte verabreichung eines heilmittels an blut.
ATE4808T1 (de) Piperidinderivate von 3-hydroxy-thiophen-2carbons[ureestern,ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
ATE13633T1 (de) Verfahren zur herstellung von hochgereinigtem antihaemophiliefaktor.
ATE53384T1 (de) 3-mercapto-2-oxo-1-pyrrolidinessigsaeurederivate verfahren zur herstellung und pharmazeutische zusammensetzungen die sie enthalten.
JPS62294620A (ja) 細胞増殖抑制因子及びその調製方法